Funding opportunities
2,255 live opportunities from Grants.gov, NIH, NSF, and more.
Biomedical & Health× remove
- Host-pathogen-microbiome interactions in Mycoplasma genitalium pathology and treatment: experiments in a 3D organotypic cervical epithelium model to strengthen clinical guidelinesNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $194,375activenih
- A Novel Mitochondrial-Targeted Inhibitor of NLRP3 Inflammasome ActivationNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $251,250activenih
- Molecular Mechanisms of CbrA Transceptor Signaling in PseudomonasNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $413,092activenih
- Immunometabolism of myeloid suppressor cell responses to M. tuberculosis in PWHNational Institute of Allergy and Infectious DiseasesPAR-25-316 closes 5/31/2028up to $500,500activenih
- Augmented-reality guided lumpectomyNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $395,973activenih
- Peptidoglycan modification activating NOD2 in N. gonorrhoeae infectionsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $233,250activenih
- Single Cell-Resolution Imaging of Drug Resistance via Toxic Metal Pre-exposure in Lung Patient Tumor MicroenvironmentNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $395,973activenih
- Patient attitudes towards male partner therapy for bacterial vaginosisNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $233,188activenih
- Preclinical Pluripotent Stem Cell Investigation for Vascular TherapeuticsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $335,917activenih
- Non-Infectious VZV EVs as a novel modulator of HSV-1 NeurovirulenceNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $429,000activenih
- Cytomegalovirus-Induced Immune Remodeling and Susceptibility to Mycobacterium tuberculosisNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $463,601activenih
- Species-specific yeast insecticides for Culicoides biting midge controlNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $435,875activenih
- Heterogeneity in autoimmune myasthenia gravis: classifying disease variants by unique immune mechanisms to inform personalized therapeutic strategiesNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $251,938activenih
- Investigating the Impact of Cadmium on Immune Function and Viral Dynamics in Jamaican Fruit Bats (Artibeus jamaicensis)National Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $146,459activenih
- How Feedback Shapes Sensory Representations During CognitionNational Institute of Neurological Disorders and StrokeRFA-NS-24-030 closes 5/31/2028up to $44,714activenih
- Fluorescence lifetime imaging for quantitative assessment of in vivo PD-L1 target engagement.National Cancer InstitutePAR-25-346 closes 5/31/2028up to $437,113activenih
- Role of the DEAH-Box RNA helicase DHX29 during Class Switch Recombination in B-cellsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $195,625activenih
- Understanding how environmental microbiomes shape animal sensationNational Institute of General Medical SciencesPA-24-194 closes 5/31/2028up to $125,000activenih
- Engineered enterococcal phages as immunomodulatory agents in the intestineNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $429,000activenih
- Unveiling the origin of tumor-reactive regulatory T cells in patients with mismatch repair proficient colon cancerNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $437,113activenih
- Deep phenotyping of DR15-restricted CD4+ T cells specific for Epstein-Barr virus epitopes in the spinal fluid and blood of people with multiple sclerosisNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $247,500activenih
- Probing the Mechanism of HIV-1 Gag Localization to Transcription SitesNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $430,650activenih
- Harnessing in-tissue antibodies for therapeutic HSV controlNational Institute of Allergy and Infectious DiseasesRFA-AI-24-068 closes 5/31/2028up to $238,899activenih
- Platforms for targeted protein degradation in mycobacteriaNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $422,125activenih
- Next-Generation Oncoproteomic Sequencing and Precision ProfilingNational Cancer InstitutePAR-25-346 closes 5/31/2028up to $418,854activenih